Enlivex Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 700,844 | 3.27% |
| Individual Insiders | 1,232,783 | 5.76% |
| VC/PE Firms | 1,421,326 | 6.64% |
| Hedge Funds | 2,139,000 | 9.99% |
| General Public | 15,912,078 | 74.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 2,139,000 | US$1.8m | 25.8% | 0.06% | |||
| 1,421,326 | US$1.2m | 0% | 2.05% | |||
| 774,033 | US$651.0k | 0% | no data | |||
| 245,754 | US$206.7k | 0.35% | no data | |||
| 242,345 | US$203.8k | 0% | no data | |||
| 181,228 | US$152.4k | 0.94% | no data | |||
| 99,274 | US$83.5k | -1.68% | no data | |||
| 74,789 | US$62.9k | 4.32% | no data | |||
| 71,645 | US$60.3k | 0% | no data | |||
| 51,397 | US$43.2k | 0% | 0.06% | |||
| 37,191 | US$31.3k | -1.17% | no data | |||
| 30,000 | US$25.2k | 0% | no data | |||
| 25,495 | US$21.4k | 0% | no data | |||
| 22,659 | US$19.1k | -8.71% | no data | |||
| 13,935 | US$11.7k | 21.9% | no data | |||
| 10,420 | US$8.8k | 0% | no data | |||
| 9,184 | US$7.7k | 0% | no data | |||
| 8,750 | US$7.4k | 0% | no data | |||
| 5,977 | US$5.0k | 0% | no data | |||
| 5,730 | US$4.8k | -0.33% | no data | |||
| 5,064 | US$4.3k | 50% | no data | |||
| 3,217 | US$2.7k | 20,000% | no data | |||
| 3,000 | US$2.5k | 0% | no data | |||
| 3,000 | US$2.5k | 0% | no data | |||
| 2,742 | US$2.3k | 50% | no data |